During the exocytosis of vesicles, it increases the bioavailability of growth factors, such as VEGF and HGF, and cytokines, such as IL‐6, IL‐8, and CCL2, in the ECM promoting tumor growth and angiogenesis [8, 15, 16]. The gene discussed is VEGFA; the disease is neoplasm.